Pancreatic Differentiation of Cord Blood Stem Cells using Smart Surfaces. Cord blood cells obtained at the time of delivery of a baby are a valuable resource that have the potential to develop into many cell types. This Project entails attaching stem cells derived from cord blood to appropriate 3 dimensional smart surfaces, and examining the ability of such cells to develop into insulin-producing cells. An understanding of how to coax stem cells, seeded on to smart surfaces, to develop into ma ....Pancreatic Differentiation of Cord Blood Stem Cells using Smart Surfaces. Cord blood cells obtained at the time of delivery of a baby are a valuable resource that have the potential to develop into many cell types. This Project entails attaching stem cells derived from cord blood to appropriate 3 dimensional smart surfaces, and examining the ability of such cells to develop into insulin-producing cells. An understanding of how to coax stem cells, seeded on to smart surfaces, to develop into mature cells with different functions will enhance our ability to understand how cells develop. As well, it enhance the potential usefulness of cord blood for research purposes. Read moreRead less
Heparan sulfate complexes with VEGF for control of angiogenesis in tissue engineered constructs. The national/community benefits that will arise from this work include, the generation of knowledge related to the growth of blood vessels in the presence of a synthetic polymer that has been made to look like the natural polymers present in the body. This will lead to an understanding of the underlying mechanisms involved that may have down stream effects relevant to the replacement of many types o ....Heparan sulfate complexes with VEGF for control of angiogenesis in tissue engineered constructs. The national/community benefits that will arise from this work include, the generation of knowledge related to the growth of blood vessels in the presence of a synthetic polymer that has been made to look like the natural polymers present in the body. This will lead to an understanding of the underlying mechanisms involved that may have down stream effects relevant to the replacement of many types of tissues being generated for clinical applications, including possible applications in the treatment of heart disease, the largest killer of people in the Western world. Read moreRead less
Blood component interactions with polysaccharide biomaterials for vascular applications. Heart disease is the major killer of people in Australia and the Western world. It is due mainly to the blockage of vessels supplying the muscle of the heart with blood and nutrients, which can be replaced or by-passed but the supply of native vessels in the body is limited. Tissue engineering laboratories have been trying to develop blood vessels for this use for many years without significant success. T ....Blood component interactions with polysaccharide biomaterials for vascular applications. Heart disease is the major killer of people in Australia and the Western world. It is due mainly to the blockage of vessels supplying the muscle of the heart with blood and nutrients, which can be replaced or by-passed but the supply of native vessels in the body is limited. Tissue engineering laboratories have been trying to develop blood vessels for this use for many years without significant success. This application plans to understand the molecular signals contained within the sugar sequences used in a commonly used biomaterial chitosan that may be used in the construction of synthetic vascular grafts. If we can understand how blood cells interact with this biomaterial, we may be able to develop a blood vessel in the laboratory.Read moreRead less
Biochemistry of tropoelastin and elastin. Elastin is the main protein responsible for the elasticity of vertebrate tissues. The Weiss Lab makes large quantities of full-length tropoelastin, which is crosslinked to make elastin. We want to examine the biochemistry of tropoelastin, learn how its domains participate in elastin structure and assembly, and explore cellular responses to our synthetic elastin biomaterial. Remarkably little is known of this biochemistry because elastin is a highly cross ....Biochemistry of tropoelastin and elastin. Elastin is the main protein responsible for the elasticity of vertebrate tissues. The Weiss Lab makes large quantities of full-length tropoelastin, which is crosslinked to make elastin. We want to examine the biochemistry of tropoelastin, learn how its domains participate in elastin structure and assembly, and explore cellular responses to our synthetic elastin biomaterial. Remarkably little is known of this biochemistry because elastin is a highly cross-linked and substantially insoluble macroscopic network of tropoelastin multimers. Our availability of tropoelastin and synthetic elastin now makes these studies possible.Read moreRead less
Biomolecular surface interactions with smart biomaterials. Current materials used for medical implants are often recognised by the body as foreign materials causing implant rejection or encapsulation. Research into the interactions between biological molecules and chemically and topographically modified materials will aid in the development of new materials and devices that optimise the body's response to the implanted material. The new materials and surfaces developed from this research will pr ....Biomolecular surface interactions with smart biomaterials. Current materials used for medical implants are often recognised by the body as foreign materials causing implant rejection or encapsulation. Research into the interactions between biological molecules and chemically and topographically modified materials will aid in the development of new materials and devices that optimise the body's response to the implanted material. The new materials and surfaces developed from this research will provide longer lasting implants and reduce the need for repeated operations. This will improve the quality of life for implant recipients and reduce health care costs.Read moreRead less
Targeted growth factor delivery using natural polysaccharide materials for bone regeneration. This proposal addresses the core issue of nano-biomaterials capable of encouraging bone growth and providing better and more complete healing of bone fractures. Australia will benefit firstly through improved health outcomes by providing material-based solutions to address slow or non-healing fractures, which are increasingly prevalent in the aging population in Australia. This will have a further benef ....Targeted growth factor delivery using natural polysaccharide materials for bone regeneration. This proposal addresses the core issue of nano-biomaterials capable of encouraging bone growth and providing better and more complete healing of bone fractures. Australia will benefit firstly through improved health outcomes by providing material-based solutions to address slow or non-healing fractures, which are increasingly prevalent in the aging population in Australia. This will have a further benefit to the Australian economy improving the quality of life enabling people to work longer and reducing the need for further surgical intervention. This proposal will also have benefits to Australia through training future researchers in this field which will in turn provide economic growth through the development of Australian industries.Read moreRead less
Design and characterisation of a polysaccharide-based biomaterial for tissue adhesion. This proposal aims to design a new bio-adhesive material and study the mechanisms of action for tissue adhesion. Current suture technology is inadequate for anything but simple repairs and the alternative offered by surgical glues available today is at most augmentation of suturing. Combination of a strong adhesive biomaterial with factors for accelerating wound healing will generate a novel material technolo ....Design and characterisation of a polysaccharide-based biomaterial for tissue adhesion. This proposal aims to design a new bio-adhesive material and study the mechanisms of action for tissue adhesion. Current suture technology is inadequate for anything but simple repairs and the alternative offered by surgical glues available today is at most augmentation of suturing. Combination of a strong adhesive biomaterial with factors for accelerating wound healing will generate a novel material technology that, by uniting wound closure with sealing, addresses an unmet need in surgery.
The primary outcomes of these investigations will be:
1. advancement of knowledge in theories of tissue-biomaterial adhesion mechanisms
2. knowledge of effects of visible light from laser diodes on cells and isolated tissue
3. a biocompatible, visible light activated adhesive film for tissue repair based on chitosan polysaccharides
Read moreRead less
Interfacial interactions with hydrogel biomaterials. The interactions between cells of the body and the surfaces of medical implants are controlled largely by the molecules that are adsorbed on the surface. The aim of this project is to evaluate the effect of modifying hydrogel biomaterials on the interactions of the molecules with the hydrogel. This, in turn, allows us to determine the factors affecting the control of the cell's response. The significance of this work is in the improved ability ....Interfacial interactions with hydrogel biomaterials. The interactions between cells of the body and the surfaces of medical implants are controlled largely by the molecules that are adsorbed on the surface. The aim of this project is to evaluate the effect of modifying hydrogel biomaterials on the interactions of the molecules with the hydrogel. This, in turn, allows us to determine the factors affecting the control of the cell's response. The significance of this work is in the improved ability to control cellular responses to implants. Such improved response will result in better health outcomes for patients, and outcomes in the form of papers and intellectual property.
Read moreRead less
Novel biomimetic vascular biomaterials using extracellular matrix molecules. There is currently a pressing, unmet need for biodegradable, functional biomaterials that support endothelial cell interactions and vascular regeneration. Lack of sufficient vascular regeneration is the biggest obstacle in translating advances in biomaterials development to clinical, diagnostic and research applications. This project aims to address this need by developing novel biomaterial platforms that mimic the extr ....Novel biomimetic vascular biomaterials using extracellular matrix molecules. There is currently a pressing, unmet need for biodegradable, functional biomaterials that support endothelial cell interactions and vascular regeneration. Lack of sufficient vascular regeneration is the biggest obstacle in translating advances in biomaterials development to clinical, diagnostic and research applications. This project aims to address this need by developing novel biomaterial platforms that mimic the extracellular matrix of the vascular niche. We plan to utilise unique extracellular matrix domains and bioprinting techniques to control and guide endothelial cell functions. We could thus contribute to the knowledge base in vascular biology and bioengineering, forming the basis for vascular materials of the future.Read moreRead less
Biomimetic blood bag materials for prolonged platelet storage. Platelet storage is limited to five to seven days before there is a reduction in viable platelets. This results in a continual mismatch between supply and demand resulting in patients in remotes areas or those that have rare phenotypes missing out on platelets. It also results in the wastage of platelets because they expire before they can be used clinically. This project aims to extend the platelet shelf life beyond seven days by de ....Biomimetic blood bag materials for prolonged platelet storage. Platelet storage is limited to five to seven days before there is a reduction in viable platelets. This results in a continual mismatch between supply and demand resulting in patients in remotes areas or those that have rare phenotypes missing out on platelets. It also results in the wastage of platelets because they expire before they can be used clinically. This project aims to extend the platelet shelf life beyond seven days by developing biomimetic blood bag materials that reflect the natural molecular structures of blood vessels through the use of novel synthetic and biological materials. With the realisation of longer platelet storage times, this project aims to have significant impacts on the health and economic benefits of Australians.Read moreRead less